文献速递慢阻肺呼吸危重症与机械通气

NIVO评分:预测需辅助通气的慢阻肺急性加重患者院内死亡

The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation.
PubMed 文献 · Eur Respir J · 2021-08-12

该研究基于两个医院连续收治的AECOPD合并急性高碳酸血症性呼吸衰竭并接受辅助通气(主要为无创通气)的患者,开发并外部验证了NIVO评分。推导队列n=489,院内死亡率25.4%;验证队列n=733,院内死亡率20.1%。NIVO评分采用六个简单分类变量,在验证队列中AUC为0.79,校准度和区分度良好,优于预设对照评分。

要点

  • NIVO评分用于预测AECOPD需辅助通气患者的院内死亡。
  • 评分基于六个简单分类变量,验证队列AUC为0.79。
  • NIVO评分优于预设对照评分,可辅助治疗决策。

核心结论

  • NIVO评分能较好预测AECOPD需辅助通气患者的院内死亡,且优于预设对照评分。

研究设计与样本

  • 推导队列为两所医院连续收治的AECOPD合并AHRF接受辅助通气患者,n=489。
  • 外部验证为10中心前瞻性研究,n=733。
  • 研究遵循TRIPOD推荐。

主要发现

  • 推导队列院内死亡率为25.4%,验证队列为20.1%。
  • NIVO评分在验证队列中AUC为0.79,校准度和区分度良好。

关键数值与推荐

  • NIVO评分包含六个变量:扩展MRC呼吸困难评分1-4/5a/5b、入院至酸中毒时间>12 h、pH<7.25、房颤、GCS≤14、胸片实变。

临床怎么用

  • 可用于与患者及家属沟通、辅助治疗升级决策、挑战悲观情绪及比较风险调整后结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Acute exacerbations of COPD (AECOPD) complicated by acute (acidaemic) hypercapnic respiratory failure (AHRF) requiring ventilation are common. When applied appropriately, ventilation substantially reduces mortality. Despite this, there is evidence of poor practice and prognostic pessimism. A clinical prediction tool could improve decision making regarding ventilation, but none is routinely used. METHODS: Consecutive patients admitted with AECOPD and AHRF treated with assisted ventilation (principally noninvasive ventilation) were identified in two hospitals serving differing populations. Known and potential prognostic indices were identified a priori. A prediction tool for in-hospital death was derived using multivariable regression analysis. Prospective, external validation was performed in a temporally separate, geographically diverse 10-centre study. The trial methodology adhered to TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) recommendations. RESULTS: Derivation cohort: n=489, in-hospital mortality 25.4%; validation cohort: n=733, in-hospital mortality 20.1%. Using six simple categorised variables (extended Medical Research Council Dyspnoea score 1-4/5a/5b, time from admission to acidaemia >12 h, pH <7.25, presence of atrial fibrillation, Glasgow coma scale ≤14 and chest radiograph consolidation), a simple scoring system with strong prediction of in-hospital mortality is achieved. The resultant Noninvasive Ventilation Outcomes (NIVO) score had area under the receiver operating curve of 0.79 and offers good calibration and discrimination across stratified risk groups in its validation cohort. DISCUSSION: The NIVO score outperformed pre-specified comparator scores. It is validated in a generalisable cohort and works despite the heterogeneity inherent to both this patient group and this intervention. Potential applications include informing discussions with patients and their families, aiding treatment escalation decisions, challenging pessimism and comparing risk-adjusted outcomes across centres.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Hartley T, Lane ND, Steer J, et al. The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation. Eur Respir J. 2021. PMID: 33479109. doi:10.1183/13993003.04042-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。